UnitedHealth Group (NYSE:UNH - Free Report) had its target price reduced by UBS Group from $400.00 to $385.00 in a research report report published on Wednesday,Benzinga reports. They currently have a buy rating on the healthcare conglomerate's stock.
A number of other research firms have also commented on UNH. Piper Sandler decreased their price objective on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a research note on Tuesday, June 3rd. Wells Fargo & Company reiterated an "overweight" rating on shares of UnitedHealth Group in a report on Friday, June 6th. Wall Street Zen lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. TD Cowen cut UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target for the company. in a research note on Monday, May 19th. Finally, Truist Financial restated a "buy" rating and issued a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average target price of $415.57.
Get Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Price Performance
Shares of UNH traded up $6.23 during mid-day trading on Wednesday, hitting $308.85. The company's stock had a trading volume of 13,584,804 shares, compared to its average volume of 7,465,895. The stock has a market capitalization of $280.17 billion, a price-to-earnings ratio of 12.93, a PEG ratio of 1.43 and a beta of 0.44. UnitedHealth Group has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a 50-day moving average price of $336.21 and a 200 day moving average price of $454.51.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the company posted $6.91 EPS. On average, research analysts predict that UnitedHealth Group will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were paid a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.86%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is currently 37.02%.
Insider Activity at UnitedHealth Group
In other UnitedHealth Group news, Director John H. Noseworthy purchased 300 shares of the business's stock in a transaction on Wednesday, May 14th. The stock was acquired at an average price of $312.16 per share, with a total value of $93,648.00. Following the acquisition, the director now directly owns 6,063 shares of the company's stock, valued at $1,892,626.08. This trade represents a 5.21% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the firm's stock in a transaction on Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director now owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders bought 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the stock. AG2R LA Mondiale Gestion D Actifs bought a new position in UnitedHealth Group in the 1st quarter valued at about $17,766,000. Voya Investment Management LLC raised its holdings in UnitedHealth Group by 33.1% in the 1st quarter. Voya Investment Management LLC now owns 1,127,586 shares of the healthcare conglomerate's stock valued at $590,463,000 after acquiring an additional 280,554 shares during the period. Maple Capital Management Inc. raised its holdings in UnitedHealth Group by 1.7% in the 1st quarter. Maple Capital Management Inc. now owns 68,861 shares of the healthcare conglomerate's stock valued at $36,066,000 after acquiring an additional 1,129 shares during the period. Nicola Wealth Management LTD. raised its holdings in UnitedHealth Group by 2.2% in the 1st quarter. Nicola Wealth Management LTD. now owns 46,400 shares of the healthcare conglomerate's stock valued at $24,302,000 after acquiring an additional 1,000 shares during the period. Finally, Cim LLC raised its holdings in UnitedHealth Group by 1.2% in the 1st quarter. Cim LLC now owns 38,519 shares of the healthcare conglomerate's stock valued at $20,174,000 after acquiring an additional 467 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.
UnitedHealth Group Company Profile
(
Get Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report